Agree Realty is an integrated real estate investment trust primarily focused on the ownership, acquisition, development and management of retail properties net leased to tenants. The company's assets are held by, and all of its operations are conducted through, directly or indirectly, Agree Limited Partnership, of which the company is the sole general partner and in which it holds a majority interest.

AnaptysBio is a clinical stage biotechnology company developing antibody product candidates. Etokimab, the company's anti-IL-33 antibody drug candidate, inhibits the activity of the interleukin-33 cytokine that is applicable to the treatment of atopic inflammatory disorders, such as moderate-to-severe atopic dermatitis, eosinophilic asthma, chronic rhinosinusitis with nasal polyps, and potentially other allergic conditions. ANB019 inhibits the interleukin-36 receptor, for the treatment of rare inflammatory diseases including generalized pustular psoriasis and palmoplantar pustulosis. The company's wholly-owned pipeline includes anti-inflammatory checkpoint receptor modulator antibodies.

Anixa Biosciences is a biotechnology company focused on using the body's immune system to diagnose, treat and prevent cancer. The company's subsidiary, Anixa Diagnostics Corporation, develops Cchek?, a platform for non-invasive blood tests for the early detection of cancer. The company's subsidiary, Certainty Therapeutics, Inc., develops immuno-therapy drugs against cancer. The company has focused on the development of a treatment for ovarian cancer. The company is also engaged in limited patent licensing activities in the area of encrypted audio/video conference calling.

Codexis discovers, develops and sells proteins to its clients. The company has two segments: Performance Enzymes, which uses its technology to develop enzymes for customers using next generation sequencing and polymerase chain reaction for in vitro molecular diagnostic and molecular biology research applications; and Novel Biotherapeutics, in which it has announced a global development, option and license agreement with Societe des Produits Nestle S.A. to develop CDX-6114, its own orally administrable enzyme therapeutic candidate for the potential treatment of phenylketonuria. The company's products include protein catalysts, chemical intermediates and Codex? biocatalyst panels and kits.

Constellation Brands is an international beverage alcohol company. The company is a producer and marketer of beer, wine and spirits with operations in the U.S., Mexico, New Zealand, Italy and Canada. The company has two segments: Beer, in which the company is engaged in the U.S. beer market that includes the imported, craft, domestic super premium, and alternative beverage alcohol categories and it has the right to import, market and sell these Mexican beer brands in the U.S.; and Wine and Spirits, in which its wine portfolio is supported by grapes purchased from independent growers, primarily in the U.S., New Zealand and Chile, and vineyard holdings in the U.S., New Zealand and Italy.

Cytosorbents is engaged in critical care immunotherapy, investigating and commercializing its CytoSorb blood purification technology to reduce uncontrolled inflammation in hospitalized patients around the world, to prevent or treat multiple organ failure in life-threatening illnesses and cardiac surgery. CytoSorb, the company's primary product, is approved in the European Union as an extracorporeal cytokine filter and is designed to reduce the cytokine storm that could otherwise cause massive inflammation, organ failure and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury, and pancreatitis. CytoSorb is used during and after cardiac surgery.

Dorchester Minerals is engaged in the acquisition, ownership and administration of Royalty Properties and Net Profits Interests (NPIs). The Royalty Properties consist of producing and nonproducing mineral, royalty, overriding royalty, net profits, and leasehold interests located in several counties and parishes in several states. The NPIs represent net profits overriding royalty interests in various properties owned by the operating partnership. The company's general partner is Dorchester Minerals Management LP, which is managed by its general partner, Dorchester Minerals Management GP LLC.

Eton Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing pharmaceutical products utilizing the FDA's 505(b)(2) regulatory pathway. The company's product candidates focuses on liquid formulation, including injectables, oral liquids, and ophthalmics. The company's formula products include: EM-100, an ophthalmic solution indicated for the treatment of allergic conjunctivitis; ET-202, an injectable product candidate to be used in the hospital setting; ET-103, an oral liquid formulation of levothyroxine for the treatment of hypothyroidism; and ET-203, an injectable product candidate to be used in the hospital setting.

FB Financial is a bank holding company. Through its bank subsidiary, FirstBank (the Bank), the company is engaged in providing a suite of commercial and consumer banking services to clients. The company's commercial lending products include working capital lines of credit, equipment loans, owner-occupied and non-owner-occupied real estate construction loans, mini-perm real estate term loans, and cash flow loans to a mix of clients, including small and medium sized businesses. The company's consumer lending products include first and second residential mortgage loans, home equity lines of credit and consumer installment loans to purchase cars, boats and other recreational vehicles.

Lakeland Industries manufactures and sells a line of industrial protective clothing and accessories. The company's principal products are: limited use/disposable protective clothing, which includes coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps and smock; chemical protective suits, which are worn by individuals on hazardous material teams and within general industry; firefighting and heat protective apparel for use by domestic and foreign fire departments; reusable woven garments, which include electrostatic dissipative apparel used by electric and gas utilities; high visibility clothing, which includes vests, and T-shirts; and gloves and sleeves.

Lamb Weston Holdings is a producer, distributor, and marketer of frozen potato products. French fries represent the majority of the company's frozen potato product portfolio. The company's segments include: Global, which includes branded and private label frozen potato products sold in North America and international markets; Foodservice, which includes branded and private label frozen potato products sold throughout the U.S. and Canada; Retail, which includes consumer facing retail branded and private label frozen potato products sold primarily to grocery, mass merchants, club, and specialty retailers; and Other, which includes the company's vegetable and dairy businesses.

MasterCraft Boat Holdings is a holding company. Through its subsidiaries, the company is a designer, manufacturer, and marketer of recreational powerboats sold under MasterCraft, NauticStar, Crest, and Aviara brands. The company's segments include: MasterCraft, which produces MasterCraft and Aviara boats for water skiing, wakeboarding, wake surfing, and general recreational boating; NauticStar, which produces boats for saltwater fishing and general recreational boating; and Crest, which produces pontoon boats which are primarily used for general recreational boating. In addition, the company provides various accessories, including trailers and aftermarket parts.

Neogen develops, manufactures, and markets a line of products for food and animal safety. The company's segments are: Food Safety, which is engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation; and Animal Safety, which is engaged in the development, production and marketing of products dedicated to animal safety, including a range of consumable products marketed to veterinarians and animal health product distributors, and provides genomic identification and related interpretive bioinformatic services.

Pennant Group is a holding company. Through its subsidiaries, the company is a provider healthcare services through 63 home health and hospice agencies and 52 senior living communities located throughout Arizona, California, Colorado, Idaho, Iowa, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming.

Progyny operates as a fertility benefits management company in the United States. The company offers patients a benefits solution with education and guidance from a Patient Care Advocate and access to a network of fertility specialists. The company also aims to reduce healthcare costs for employers through their operations.